Claims for Patent: 8,558,057

Summary for Patent: 8,558,057

Title:	Antifungal plant proteins and methods of their use
Abstract:	DNA constructions that provide for production of potent antifungal proteins in transgenic plants and transformed yeast cells are described. Methods of using the DNA constructs to produce transgenic plants that inhibit growth of plant pathogenic fungi are also disclosed. The use of transformed yeast cells containing the DNA constructs to produce the antifungal proteins and methods of isolating the antifungal proteins are also described.
Inventor(s):	Shah; Dilip Maganial (St. Louis, MO), Snyder; Anita K. (St. Louis, MO)
Assignee:	Donald Danforth Plant Science Center (St. Louis, MO)
Application Number:	13/430,143
Patent Claims:	1. An isolated DNA construct comprising a heterologous promoter, a sequence that encodes a MtDef4 polypeptide comprising the amino acid sequence shown in SEQ ID NO:80, and a polyadenylation sequence, wherein said promoter, said sequence encoding a MtDef4 polypeptide and said polyadenylation sequence are operably linked. 2. The isolated DNA construct of claim 1, further comprising a sequence that encodes a signal peptide, wherein said sequence that encodes said signal peptide is operably linked to said sequence that encodes said MtDef4 polypeptide. 3. The isolated DNA construct of claim 2, wherein said signal peptide is selected from the group consisting of a yeast signal peptide, a monocot plant signal peptide, a dicot plant signal peptide, and a synthetic signal peptide. 4. The isolated DNA construct of claim 1, wherein said sequence that encodes a MtDef4 polypeptide is contained within the sequence AL386553 (SEQ ID NO: 102). 5. The isolated DNA construct of claim 1, wherein said promoter and said polyadenylation sequence provide for expression of operably linked sequences when introduced into a transgenic plant. 6. The isolated DNA construct of claim 5, wherein said promoter is selected from the group consisting of a constitutive promoter, a tissue specific promoter, a stress induced promoter, and a fungal infection induced promoter. 7. The isolated DNA construct of claim 5, wherein said DNA construct further comprises an intron sequence that provides for expression of operably linked sequences when introduced into the nuclear genome of a plant and wherein said intron sequence is operably linked to said promoter, to said sequence that encodes a signal peptide, to said sequence that encodes a mature MtDef4 polypeptide, and to said polyadenylation sequence. 8. The isolated DNA construct of claim 5, wherein said DNA construct further comprises a sequence encoding a selectable marker. 9. The isolated DNA construct of claim 5, wherein said DNA construct further comprises a sequence encoding a scoreable marker. 10. A transgenic plant comprising the DNA construct of claim 1, wherein said promoter and said polyadenylation sequence of said DNA construct provide for expression of operably linked sequences when introduced into a transgenic plant. 11. A transgenic plant that inhibits the growth of a plant pathogenic fungus, said transgenic plant being produced by a process comprising the steps of: a. introducing the DNA construct of claim 5 into a plant, a plant cell or a plant tissue; and b. obtaining a transgenic plant comprising said DNA construct, wherein said transgenic plant obtained in step (b) expresses a plant pathogenic fungus inhibitory amount of said MtDef4 polypeptide.

Details for Patent 8,558,057

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2026-12-22
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2026-12-22
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2026-12-22